Kymera Therapeutics Doses First Patient in Phase 1 Oncology Trial of MDM2 Degrader KT-253
KT-253 is a novel, highly potent and selective heterobifunctional degrader of the MDM2 oncoprotein with…
KT-253 is a novel, highly potent and selective heterobifunctional degrader of the MDM2 oncoprotein with…
CUPERTINO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
CUPERTINO, Calif., May 19, 2023 (GLOBE NEWSWIRE) — Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva”…
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) — With more than 300,000 fans expected to…
Empowering the warfighter with actionable intelligence from the edge to the enterprise SAN DIEGO–(BUSINESS WIRE)–#CMPS—Cubic…
Toronto, Ontario–(Newsfile Corp. – May 19, 2023) – Tenet Fintech Group Inc. (CSE: PKK) (OTC…
Toronto, Ontario–(Newsfile Corp. – May 19, 2023) – American Aires Inc. (CSE: WIFI) (OTC Pink:…
KUALA LUMPUR, May 19, 2023 – (ACN Newswire) – Leading global information and communications technology…
NET Power adds another strategic investor in SK and increases total committed capital to $560…
BOSTON–(BUSINESS WIRE)–Committed to enhancing the online safety of its users, PureVPN – a leading virtual…
Suntuity is contributing to America’s transition to solar energy and home electrification. The Company conducts…
Financial Institutions can now provide REPAY’s payment solution to their users through Q2’s Digital Banking…
– Oral presentation highlights EPI-321 effects on multiple clinically relevant markers – – IND application…
RNA Gene Writing™ platform demonstrates continued advances in rewriting to correct pathogenic mutations responsible for…
Revenue for the first three months of 2023 increased to $15.9 million, compared to…
Revenue for the first three months of 2023 increased to $15.9 million, compared to $0.8…
SAN FRANCISCO, May 19, 2023 (GLOBE NEWSWIRE) — Gainsight announced the winners of its 2023…
Hokolite is a prominent illumination company that has recently released an update to its camping…
TOKYO, May 19, 2023 – (JCN Newswire) – Hitachi Astemo, Ltd. (“Hitachi Astemo”) deeply apologizes…
– Company’s metagenomics-derived gene editing toolbox shows activity, specificity, and translatability for broad use in…